Royal London boosts its critical illness cover to help pay more claims
Royal London, the UK’s largest life, pensions and investment mutual, today announces it has widened the coverage on its critical illness cover by improving, changing and adding definitions to expand the scope for claims.
The mutual has reviewed its definitions and processes, and identified how conditions can be improved to deliver long term value for its customers.
This update is the latest in Royal London’s journey to improving the customer experience, and follows the announcement that the business had updated its pre-sale underwriting tool to widen the scope of medical conditions covered from 60 to over 3,600.
Jennifer Gilchrist, protection expert at Royal London, commented:
"As well as implementing ABI minimum standard changes, we have enhanced our critical illness cover by concentrating on cancer, severe mental health, type 1 diabetes, and bowel disease cover definitions. The changes have been driven by analysis of our claims experience and insight to maximise value and help deliver the best possible outcomes for customers.
"While we have made our definitions more precise, our aim is to provide improved clarity at the point of claim so we can enable quicker payments for customers at their point of need."
As well as new and improved additional cover conditions, the pay out is also increasing from £30k to £35k, to reflect increasing living costs and to better support clients’ needs.
| Full definitions | |
| Added two new definitions |
|
| Improved/changed five existing definitions in line with ABI minimum standards |
|
| Additional cover | |
| Pay out increase |
|
| Pay out increase Four new additional cover conditions |
|
| Improved/changed four additional cover conditions |
|
| Children’s cover | |
| Improved child specific condition |
|
Alan Lakey, director at CIExpert, said:
"2023 has seen the demise of two major protection brands so it is heart-warming to see a major protection insurer affirm its commitment to the market by increasing both the quality and the amounts being paid out for critical illness claims. Additional payments for bowel disease and cutaneous lymphoma are both unique to Royal London and the improvements secure their position as a top-quality critical illness provider."
Jennifer Gilchrist, continues:
"When it comes to critical illness cover, there’s been a fairly consistent pattern of claims being paid over a long period of time. We have added and changed definitions now as it’s important that cover continues to evolve to keep pace with medical science and concentrates on conditions where we can provide improved outcomes for customers now and in the future."
For further information please contact:
Neil Cameron, PR Manager
- Email: neil.cameron@royallondon.com
- Mob: 07919 171969
About Royal London
Royal London is the largest mutual life, pensions and investment company in the UK, and in the top 30 mutuals globally*, with assets under management of £173bn, 8.7 million policies in force and over 4,500 employees. Figures quoted are as at 31 December 2024. Learn more at royallondon.com.
*Based on total 2022 premium income. ICMIF Global 500, 2024
More press releases you might like
